Promedix Inc.

ProMedix “FlowSense” rapidly and noninvasively identifies worsening peripheral blood flow, one of the earliest physiological indications of sepsis. FlowSense monitors changes in the capillaries of the fingertips, indicating impaired circulation; facilitating earlier therapeutic interventions by physicians and improving patient outcomes.